Drug Approval Package: ProvayBlue (Methylene blue injection) – Drugs@FDA overview page, NDA 204630 (2017)

Government Record · U.S. Food and Drug Administration, Center for Drug Evaluation and Research · February 13, 2017

U.S. Food et al., 2017-02-13: The Drugs@FDA approval-package index for NDA 204630 states the applicant (Provepharm SAS), the application number and the approval date, 8 April 2016.

Company: Provepharm SAS Application No.: 204630 Approval Date: April 8, 2016

U.S. Food et al., 2017-02-13: The Drugs@FDA approval-package index for NDA 204630 states the applicant (Provepharm SAS), the application number and the approval date, 8 April 2016. C7 – Drugs@FDA index page for NDA 204630. Page prints 'Date created: February 13, 2017'; document_date is that date. Read 2026-11-21. The page lists the review documents (Approval Letter, Summary Review, Medical, Chemistry, Pharmacology, Statistical, Microbiology, Clinical Pharmacology Biopharmaceutics, Risk Assessment, Proprietary Name reviews). Fetch route: web_extract (direct curl to accessdata index.cfm gets an 'excessive requests' apology redirect). Confirms the NDA number in the claim, 204630. Study type: regulatory record.